Scottish clinical and translational informatics company Aridhia, Netherlands-based ICT service provider Vancis, and clinical datasets experts MGRID are today announcing the expansion of their existing partnership with the launch of a new research platform service, RSRCH-Health, into the Netherlands.
The initiative will be introduced at the Health-RI conference on December 1st in Amersfoort, Netherlands to an audience of researchers, academics and clinicians who are being encouraged to work together to enable ground-breaking biomedical research.
The growth of Aridhia's operations outside the UK follows the partnership agreement with Vancis announced in mid-2015. A number of new jobs in both Scotland and the Netherlands are expected to be created as a result of this collaboration.
Based on Aridhia's AnalytiXagility data analysis platform, RSRCH-Health was first established in early 2016 to deliver a digital research environment to Radboudumc Nijmegen in a three-year deal, making it the first University Medical Centre in the Netherlands to offer a digital platform to all research teams across the institution.
Radboudumc is currently rolling out RSRCH-Health across the entire organisation, providing analytical workspaces for up to 1600 research projects to accelerate the delivery of research studies into clinical practice.
The extended Vancis, Aridhia, and MGRID collaboration - which goes by the name RSRCH - signifies continued growth for Aridhia, one of Scotland's data science success stories.
Chris Roche, Aridhia’s CEO, said of the new company: "The development of AnalytiXagility into a tailored offering for the Netherlands’ market is very exciting for Aridhia and is validation that our platform is precisely what research-driven organisations need to achieve the best outcomes.
"Research teams worldwide are realising the value in wide-scale collaboration around data, and together with Vancis and MGRID, we believe that RSRCH-Health represents an answer to the data challenges that they face."
Eli Berkelmans, RSRCH Managing Director said: "RSRCH-Health gives us the means to deliver a unique on-demand, secure platform service specifically catering to the needs of researchers.
"It is already being used at Radboudumc by a number of showcase projects and thanks to word-of-mouth, it is generating interest across Europe. We’re excited about the opportunities this opens up to us and, more importantly, to research teams worldwide."
The RSRCH-Health platform incorporates Aridhia's existing AnalytiXagility services with infrastructure expertise from Vancis, and MGRID's Aperture which speeds up creation of datasets for clinical research, to deliver a self-service capability which answers the specific requirements of the Netherland's market.
Developed to deliver rapid change by enabling a multidisciplinary, collaborative approach to biomedical research, RSRCH-Health is available via the Amsterdam based RSRCH team and is suitable for individual studies, or as the digital environment for all projects within a research-driven institution.
This partnership adds to Aridhia’s growing portfolio of European projects as it exports AnalytiXagility to prominent research collaborations across the continent, including the ground-breaking European Prevention of Alzheimer’s Dementia (EPAD) project, an Innovative Medicines Initiative funded research programme.
About Aridhia Informatics
Founded in 2007, Aridhia is a world-leading clinical and translational informatics company developing technology and capability that helps transform clinical research into clinical practice.
AnalytiXagility, Aridhia's data analytics platform and services ecosystem, brings the benefits of 3rd generation consumer technologies to the biomedical research, precision medicine and healthcare communities. The platform makes it easy to assemble people, tools and data assets in private, secure analytic workspaces that are designed to accelerate data-driven collaborative research projects.
Based in Edinburgh and Glasgow, Aridhia's 50-strong multidisciplinary team is delivering services across the UK and Europe in collaboration with the NHS, research organisations, life sciences companies, IT service providers and patients.